ArticleScientific reports2025
Comparable perioperative performance between three robotic system for robot-assisted partial nephrectomy to treat early renal cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Perioperative efficacy and safety of the MP1000 robotic surgical system versus the da Vinci robotic surgical system in urologic surgery: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Emerging robotic platforms in partial nephrectomy: a comparative systematic review and network meta-analysis.Journal of robotic surgery · 2026Pooled it
- Novel multiport robotic systems versus da vinci multiport robotic system in robot-assisted partial nephrectomy: a systematic review and meta-analysis of surgical and oncological outcomes.Journal of robotic surgery · 2026Pooled it
- A systematic review and meta-analysis of prospective studies comparing perioperative outcomes between the MP1000 and Da Vinci surgical systems for robot-assisted partial nephrectomy.Journal of robotic surgery · 2026Pooled it
- Perioperative outcomes of KangDuo versus Da Vinci robotic-assisted nephrectomy: a meta-analysis of prospective studies.Journal of robotic surgery · 2025Pooled it
- Clear Cell Renal Cell Carcinoma with Synchronous Bladder Metastasis: Diagnostic, Surgical, and Pathological Insights from a Rare Presentation.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
This study aimed to compare the safety and efficacy of robot-assisted partial nephrectomy with the two Chinese Robotic systems versus the da Vinci Xi Surgical System. This prospective analytical study included 170 patients who underwent robotic-assisted partial nephrectomy between February 2023 to June 2024. The study included 85 patients who received treatment using two Chinese robotic systems (KangDuo SR 2000: KD-SR-2, EDGE MP1000) and 85 who underwent the da Vinci (DV) surgical system during the same period. The demographic and clinical characteristics of the patients and the intraoperative and follow-up results were compared between the groups. In our study, statistically significance (p < 0.05) were observed between the Chinese robotic group and the da Vinci group in terms of operative time, intraoperative blood loss, and docking time. Among the 170 patients, there were no cases of positive surgical margins or major postoperative complications Clavien-Dindo ≥ 3. Multivariate logistic regression analysis confirmed that operative time, intraoperative blood loss, and docking time were statistically significant variables for evaluating the safety and effectiveness of both robotic systems. RAPN with Chinese robotic systems demonstrated comparable preoperative outcomes in selected parameters (operative time, blood loss, docking time) to the da Vinci system in this exploratory study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.